Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sihuan Bioengineering Sues Vitapharm to Unwind Deal

publication date: Nov 29, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Jiangsu Sihuan Bioengineering is suing Vitapharm Technology Co. of Australia. Last year, Sihuan bought China rights to Vitapharm’s sublingual drug delivery technology, but Sihuan now claims Vitapharm did not have an effective patent for the technology. Sihuan is asking a Beijing court to set aside the transaction. More details....

Stock Symbol: (SHE: 000518)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...